# A Trial of SHR-1139 in Healthy Volunteers

> **NCT07078695** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Atridia Pty Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** SHR-1139 Injection
- **DRUG:** SHR-1139 Injection
- **DRUG:** SHR-1139 Injection

## Key facts

- **NCT ID:** NCT07078695
- **Lead sponsor:** Atridia Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-08-19
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07078695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07078695, "A Trial of SHR-1139 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07078695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*